Exencial Wealth Advisors LLC Sells 4,137 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Exencial Wealth Advisors LLC cut its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 184,794 shares of the company’s stock after selling 4,137 shares during the period. Exencial Wealth Advisors LLC’s holdings in GE HealthCare Technologies were worth $14,447,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Commerzbank Aktiengesellschaft FI lifted its holdings in shares of GE HealthCare Technologies by 29.6% during the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 3,788 shares of the company’s stock worth $296,000 after purchasing an additional 865 shares during the period. Patten Group Inc. lifted its holdings in GE HealthCare Technologies by 34.1% during the 4th quarter. Patten Group Inc. now owns 10,084 shares of the company’s stock worth $788,000 after buying an additional 2,563 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in GE HealthCare Technologies by 9.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,959,256 shares of the company’s stock worth $231,355,000 after buying an additional 248,318 shares during the period. State of Michigan Retirement System grew its position in shares of GE HealthCare Technologies by 46.1% in the 4th quarter. State of Michigan Retirement System now owns 473,953 shares of the company’s stock valued at $37,054,000 after buying an additional 149,600 shares during the last quarter. Finally, Mission Wealth Management LP increased its stake in shares of GE HealthCare Technologies by 26.8% in the fourth quarter. Mission Wealth Management LP now owns 3,068 shares of the company’s stock valued at $240,000 after buying an additional 648 shares during the period. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $86.45 on Tuesday. The firm has a market capitalization of $39.53 billion, a P/E ratio of 19.97, a P/E/G ratio of 3.19 and a beta of 1.15. The firm’s 50-day moving average price is $86.31 and its 200-day moving average price is $86.14. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Finally, Citigroup increased their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.